መነሻ › የኩላሊት ችሎታ መቀነስ › New York
በNew York ለየኩላሊት ችሎታ መቀነስ የሚደረጉ ክሊኒካዊ ጥናቶች
ለየኩላሊት ችሎታ መቀነስ የሚደረጉ 16 ጥናቶች በNew York ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በNew York ውስጥ ያሉ ከተሞች
Official study text (English)
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
- Roswell Park Comprehensive, Buffalo
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT05287945Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Albany Medical College Committee of Research Involving Human Subjects, Albany
- SUNY Downstate Medical Center Brooklyn, Brooklyn
- Mattoo & Bhat Medical Associates, P.C., College Point
- እና 3 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT05485961Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD
- New York University Langone Health, New York
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ40 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2026 · NCT07224763Pivotal Study of the Velocity™ pAVF System
- Staten Island University Hospital Northwell Health, Staten Island
ተሳታዮችን በመፈለግ ላይ
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ2 ሴፕቴ 2026 · NCT07153939Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets)
- Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY, New York
ተሳታዮችን በመፈለግ ላይ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ኦገስ 2026 · NCT05465044A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
- Research Site, Ridgewood
ተሳታዮችን በመፈለግ ላይደረጃ 1/2ጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ18 እስከ 55 · ሁሉም ጾታዎች · የተሻሻለው በ14 ኦገስ 2026 · NCT06749457Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
- Albany Medical Center, Albany
ተሳታዮችን በመፈለግ ላይ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ኦገስ 2026 · NCT04634916Incremental Hemodialysis: The TwoPlus Trial
- Renal Research Institute (RRI), New York
- Northwell Health, Queens
ተሳታዮችን በመፈለግ ላይ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ6 ኦገስ 2026 · NCT05828823Moda-flx Hemodialysis System™ Under Professional Care Settings by Trained Individuals and At Home by Participants
- New York Kidney Hypertension Medicine, New Hyde Park
ተሳታዮችን በመፈለግ ላይ
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ6 ጁላይ 2026 · NCT06613568Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
- Northwell Health, New Hyde Park
ተሳታዮችን በመፈለግ ላይ
እድሜ ከ18 እስከ 84 · ሁሉም ጾታዎች · የተሻሻለው በ13 ኤፕሪ 2026 · NCT06190717Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD
- New York University Langone Health, New York
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ40 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ27 ማርች 2026 · NCT06878560Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
- SUNY Upstate Medical University, Syracuse
- Albert Einstein College of Medicine / Montefiore Medical Center, The Bronx
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ24 ማርች 2026 · NCT06217302SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
- Northwell Health, Lake Success
ተሳታዮችን በመፈለግ ላይ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ፌብሩ 2026 · NCT06001827A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
- Mount Sinai Hospital, New York
- Northwell Health, New York
- Montefiore Medical Center, The Bronx
ተሳታዮችን በመፈለግ ላይ
እድሜ ከ18 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ22 ዲሴም 2025 · NCT04671771Safety and Efficacy of Empagliflozin in Hemodialysis
- NYU Langone Health, New York
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ዲሴም 2025 · NCT05786443Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
- The Rogosin Institute, New York
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ኤፕሪ 2025 · NCT01802034ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።